Predicting Success in Phase III Studies From Phase II Results: A New Paradigm Is Needed
- 20 July 2008
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (21) , 3653-3654
- https://doi.org/10.1200/jco.2008.17.5000
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase IIIJournal of Clinical Oncology, 2008
- Phase II Oncology Trials: Let's Be PositiveClinical Cancer Research, 2005
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2004